BridgeBio Pharma, Inc. (BBIO) › Net IncomeBridgeBio Pharma, Inc. (BBIO) — Net IncomeAnnual figures by period end, from SEC filings.2017-12-31: -$43.83M2018-12-31: -$169.45M2019-12-31: -$288.58M2020-12-31: -$505.49M2021-12-31: -$586.45M2022-12-31: -$484.65M2023-12-31: -$653.25M2024-12-31: -$543.35M2025-12-31: -$732.94M-$732.94M2017-12-31Net Income (USD)2025-12-31Period endedNet IncomeChange YoYSource filing2025-12-31-$732.94M—2026-02-24From 2025-01-012024-12-31-$543.35M—2026-02-24From 2024-01-012023-12-31-$653.25M—2026-02-24From 2023-01-012022-12-31-$484.65M—2025-02-20From 2022-01-012021-12-31-$586.45M—2024-02-22From 2021-01-012020-12-31-$505.49M—2023-02-23From 2020-01-012019-12-31-$288.58M—2022-02-25From 2019-01-012018-12-31-$169.45M—2021-02-25From 2018-01-012017-12-31-$43.83M—2020-03-03From 2017-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)